IMTXWライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (26 6月 2024 @ 05:00):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States...

Stats
本日の出来高	1 302
平均出来高	0
時価総額	1.26B
EPS	$-0.0311 ( Q1 \| 2024-05-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0280 (0.93%)

AADI -0.59%

ABCL 2.38%

ABCM 0.04%

ABEO -2.82%

ABIO -0.42%

ABOS -0.93%

ABSI -1.02%

ABUS -2.46%

ABVX -1.58%

ACAD -1.15%

ACER -17.95%

ACET -2.03%

ACGN 1.29%

ACHL -4.15%

ACHV -0.22%

ACIU -1.50%

ACLX -0.73%

ACRV -1.34%

ACST -1.95%

ACXP 0.36%

ADAG -3.08%

ADAP -2.63%

ADGI 0.87%

ADIL 0.88%

ADMA -1.77%

ADPT 0.59%

ADTX -4.17%

ADVM 0.29%

ADXN -1.60%

AEON -3.21%

AEZS -3.51%

AFMD -3.85%

AGEN 0.00%

AGIO -0.29%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -5.45%

AKRO -2.26%

AKTX 2.44%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -3.10%

ALGS -3.82%

ALKS -0.33%

ALLK -8.90%

ALLO -5.83%

ALLR -4.28%

ALNA 3.16%

ALNY 0.40%

ALPN 0.02%

ALPX 0.00%

ALRN -2.50%

ALT -8.37%

ALVR -2.59%

ALXN 0.00%

ALXO -8.37%

ALZN -1.91%

AMRN 1.61%

AMTI -3.13%

ANAB 0.00%

ANEB -4.53%

ANGN 0.00%

ANIX 0.40%

ANL -3.22%

ANNX -0.22%

ANPC -3.15%

APGE -1.07%

APGN 8.48%

APGNW 30.65%

APLM 1.46%

APLS -0.25%

APLT -3.83%

APM -1.26%

APOP 0.38%

APRE 2.29%

APTO 3.38%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -3.86%

ARDS -14.23%

ARDX -1.66%

ARGX -1.11%

ARNA 0.00%

ARPO -0.90%

ARQT -0.10%

ARTL -3.62%

ARTLW 0.00%

ARVN 3.40%

ARWR -3.29%

ASLN 1.15%

ASMB -1.23%

ASND -1.94%

ATAI -0.73%

ATHA 5.50%

ATHE 0.56%

ATHX -33.50%

ATNF 3.37%

ATOS 4.85%

ATRA 0.60%

ATXI -2.50%

ATXS 0.00%

AUPH -1.26%

AURA 0.22%

AUTL -0.43%

AVBP -1.89%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -3.10%

AVTX 0.05%

AVXL -2.47%

AXLA 0.00%

AXSM -2.65%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.96%

BCAB 5.88%

BCDA -2.39%

BCDAW -41.77%

BCEL 0.00%

BCLI 3.09%

BCRX -0.99%

BCTX 2.95%

BCTXW -16.32%

BCYC 0.10%

BDRX -0.64%

BDTX -0.11%

BEAM -1.40%

BFRA -2.91%

BGNE -2.53%

BIOR -1.63%

BIVI -0.25%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.45%

BLTE -1.09%

BLU 0.03%

BLUE 0.05%

BMEA -6.67%

BMRN -0.70%

BNOX -2.51%

BNTC -2.11%

BNTX -1.16%

BOLD -6.32%

BOLT -0.05%

BPMC -0.88%

BPTH 2.38%

BPTS -13.47%

BRNS 0.37%

BRTX -0.87%

BTAI 6.78%

BTTX 1.35%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 0.47%

CABA -1.32%

CADL 1.94%

CALA 0.00%

CALC 0.00%

CALT -0.67%

CAPR -2.37%

CARA 8.17%

CARM 0.92%

CASI -3.98%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -4.89%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO -7.46%

CDIOW 24.00%

CDMO -2.11%

CDMOP 0.04%

CDT 0.00%

CDTTW -39.60%

CDTX -1.59%

CDXC -2.26%

CDXS 4.48%

CELC -3.55%

CELU -3.33%

CELUW 11.80%

CERC -1.68%

CERE -0.54%

CERO -5.96%

CEROW 0.60%

CFRX -27.95%

CGEM -3.23%

CGEN -1.66%

CGON -0.87%

CGTX -1.42%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 2.44%

CINGW 34.95%

CKPT -2.90%

CLBS -16.75%

CLDX -2.57%

CLGN 1.20%

CLLS -4.14%

CLNN 1.61%

CLNNW 0.00%

CLRB 7.72%

CLSD -3.19%

CLSN -0.68%

CLVS 0.00%

CMMB 0.97%

CMND 3.23%

CMPI 0.00%

CMPX -3.30%

CMRA 0.00%

CMRAW 33.33%

CMRX -1.63%

CNCE 0.00%

CNSP -39.79%

CNST 0.00%

CNTA -0.51%

CNTB 2.26%

CNTX -4.11%

COCP -2.80%

COEPW 32.45%

COGT -2.28%

CORT 1.54%

COYA 3.20%

CPRX -0.26%

CRBP -1.69%

CRBU -3.98%

CRDF -1.77%

CRGX -0.74%

CRIS -0.38%

CRNX -3.19%

CRSP -0.23%

CRTX 2.63%

CRVO -1.90%

CRVS 2.80%

CSBR -1.59%

CTCX -11.35%

CTIC 0.06%

CTMX -3.31%

CTNM 1.33%

CTXR 5.55%

CUE 1.04%

CVAC 1.27%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 7.46%

CYCCP 5.49%

CYCN 14.99%

CYT -2.27%

CYTK -2.38%

CYTO -2.73%

DARE 1.69%

DAWN -1.45%

DBTX -0.81%

DBVT 0.91%

DFFN 10.28%

DICE 0.06%

DMAC 13.45%

DNLI -1.18%

DNTH -6.33%

DOMH -1.58%

DRMA -0.74%

DRMAW -1.25%

DRNA 0.00%

DRTS 4.63%

DRTSW 0.00%

DRUG -7.39%

DSGN -0.60%

DTIL 0.89%

DYAI 3.29%

EARS -1.77%

EDIT -2.71%

EDSA -1.00%

EFTR 1.13%

EFTRW -74.07%

EIGR -9.21%

ELAB -1.21%

ELDN 3.36%

ELEV -2.90%

ELOX 7.69%

ELTX -0.88%

ELVN -4.24%

ELYM -1.67%

ENGN 0.00%

ENGNW 0.12%

ENLV 2.17%

ENOB 1.79%

ENSC 7.12%

ENTA -0.35%

ENTO 1.66%

ENTX 1.59%

ENVB 2.39%

EPIX -2.06%

EPRX -2.97%

EPZM 0.00%

EQ 1.50%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.96%

ERNA -0.96%

ERYP 1.30%

ESLA 2.69%

ESLAW 87.05%

ETNB -1.91%

ETON -0.30%

ETTX 0.00%

EVAX -1.78%

EVGN 0.58%

EVLO 0.00%

EWTX -0.14%

EXAI 0.57%

EXEL -0.36%

EYEG 0.04%

EYEN 3.32%

EYPT -0.42%

FATE -6.72%

FBIO 1.72%

FBIOP 0.32%

FBLG -8.86%

FBRX -6.12%

FDMT -2.64%

FENC -0.89%

FGEN -1.28%

FHTX 0.57%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.53%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.71%

FULC -3.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -7.62%

GANX -2.31%

GBIO -1.77%

GBT 0.01%

GDTC 0.50%

GERN -3.43%

GHRS -1.17%

GLMD 0.53%

GLPG -2.11%

GLSI 4.17%

GLTO -0.18%

GLUE -3.43%

GLYC -16.11%

GMAB -0.16%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.79%

GNLX 0.89%

GNPX 6.13%

GNTA 3.94%

GOSS -1.72%

GOVX -7.60%

GOVXW -49.04%

GPCR -4.28%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 2.56%

GRTX 5.14%

GTHX 0.23%

GUTS -5.77%

GXGXW 41.67%

GYRE -0.50%

HALO -1.22%

HARP 0.09%

HCWB -7.81%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.77%

HOOK 0.80%

HOTH -5.50%

HOWL -0.43%

HRMY -0.62%

HRTX 1.15%

HSTO 0.00%

HUMA 1.21%

HUMAW -0.01%

IBRX -4.95%

ICCC 0.22%

ICPT 0.21%

ICU 20.03%

ICUCW 19.08%

ICVX -0.91%

IDRA -23.04%

IDYA -1.23%

IFRX 0.00%

IGMS -0.15%

IKNA -0.30%

IKT 1.42%

IMAB -2.30%

IMCR -3.36%

IMGN 0.02%

IMGO 0.00%

IMMP 4.94%

IMMX -1.72%

IMNM -2.34%

IMNN 2.34%

IMPL -27.27%

IMRA 15.96%

IMRN 0.00%

IMRX 0.00%

IMTX -1.83%

IMTXW 6.00%

IMUX 2.78%

IMV 0.00%

IMVT -1.96%

INAB 1.10%

INBX 0.73%

INCY -1.16%

INDP 6.42%

INFI -52.38%

INKT 0.01%

INM -2.07%

INMB 0.56%

INO -4.09%

INSM -0.57%

INTS -1.47%

INVA -0.25%

INZY 0.92%

IOBT -5.51%

IONS -0.61%

IOVA -1.60%

IPA -0.27%

IPHA 5.58%

IPSC -0.78%

IRON -2.45%

ISEE 0.38%

ITOS -1.23%

ITRM 1.67%

IVA 6.96%

IVVD -1.24%

JAGX -0.53%

JANX -2.60%

JAZZ -0.96%

JNCE 0.00%

JSPR -8.08%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -0.68%

KALV -0.26%

KDNY 0.22%

KMPH -0.34%

KNSA -2.11%

KNTE -0.38%

KOD -4.72%

KPRX 1.36%

KPTI 0.00%

KRBP -10.00%

KRON 1.05%

KROS -1.66%

KRRO -3.50%

KRTX 0.03%

KRYS -0.76%

KTRA 12.08%

KTTA 8.16%

KTTAW 0.92%

KURA -1.76%

KYMR -2.63%

KYTX -5.68%

KZIA 4.11%

KZR -0.20%

LABP 0.57%

LBPH -1.82%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.34%

LENZ -4.28%

LEXX 0.00%

LEXXW -14.63%

LGND -0.78%

LGNDV 0.00%

LGVN -8.03%

LIAN -8.28%

LIFE 2.70%

LIPO -11.63%

LIXT -3.69%

LIXTW 95.35%

LJPC -0.32%

LMNL 0.12%

LOGC 1.04%

LPCN -6.88%

LPTX -0.55%

LQDA -0.24%

LRMR -0.71%

LSTA -2.17%

LTRN 1.75%

LUMO -1.32%

LVTX -2.25%

LXEO -2.07%

LXRX -2.25%

LYEL -27.70%

LYRA -0.58%

MACK 0.10%

MBIO -9.05%

MBRX -0.71%

MCRB 6.65%

MDGL -2.49%

MDNA -13.16%

MDWD 0.21%

MDXG -2.13%

MEIP 0.24%

MESO -1.93%

MGNX -4.66%

MGTA -7.74%

MGTX -1.77%

MGX -0.27%

MIRM -1.09%

MIRO 0.59%

MIST 2.69%

MITO 0.00%

MLEC -5.13%

MLECW 2.31%

MLND -5.36%

MLTX -1.31%

MLYS -0.86%

MNKD -1.15%

MNMD 0.14%

MNOV 1.47%

MNPR -5.48%

MOLN -2.95%

MOR 1.37%

MORF -3.07%

MREO -3.00%

MRKR 4.50%

MRNA -4.93%

MRNS -3.31%

MRSN -2.15%

MRTX -0.17%

MRUS -0.12%

MRVI 0.36%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 2.70%

NAMS -0.20%

NAMSW 0.43%

NAUT 2.00%

NBRV 0.71%

NBSE -1.56%

NBTX 10.35%

NCNA 1.32%

NERV -2.53%

NEXI 2.60%

NGM -1.28%

NGNE -0.31%

NKGN 3.36%

NKGNW 8.00%

NKTR -2.34%

NKTX -2.45%

NLSP -1.71%

NLSPW 26.67%

NMRA 0.29%

NMTR -42.97%

NOVN -24.84%

NRBO 14.80%

NRIX 0.10%

NRSN -2.41%

NRSNW 0.00%

NRXP -8.93%

NRXPW 14.03%

NRXS -2.73%

NTBL 2.49%

NTEC -12.45%

NTHI 0.00%

NTLA -6.91%

NTRBW -31.07%

NUVL -1.10%

NVAX -3.65%

NVCT 0.07%

NVIV -34.28%

NXTC -3.77%

NYMX -0.05%

OABI 2.25%

OABIW -10.06%

OBIO -1.46%

OBSV 0.00%

OCEA 0.35%

OCGN 3.81%

OCS -1.02%

OCUL -4.04%

OCUP 2.61%

ODT -4.27%

OKYO 1.53%

OLMA -3.67%

OMER -1.54%

OMGA 5.00%

ONCO 8.69%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 0.75%

ORGS -0.07%

ORIC -2.67%

ORMP 17.49%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.67%

OVID -2.86%

OYST 0.00%

PALI -3.25%

PASG 3.08%

PBLA 0.00%

PBM -4.00%

PBYI -0.34%

PCSA 1.83%

PCVX -0.36%

PDSB 4.60%

PEPG 3.28%

PGEN -2.09%

PHAR 1.51%

PHAS 0.00%

PHAT -2.03%

PHIO -4.96%

PHIOW 36.47%

PHVS -6.38%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.47%

PLUR 4.35%

PMN -7.47%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 2.10%

PRDS 0.93%

PRLD -3.40%

PROG -3.47%

PROK 0.45%

PRQR 1.82%

PRTA -3.09%

PRTC -0.08%

PRTG 1.95%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -2.32%

PSTX 0.00%

PTCT -0.97%

PTE -0.82%

PTGX -2.43%

PTIXW -5.10%

PULM 2.63%

PXMD 0.00%

PYPD 0.07%

PYXS -0.33%

QLGN 0.00%

QNCX 3.56%

QNRX 0.33%

QSI -11.96%

QSIAW -3.13%

QTTB -2.65%

QURE -1.35%

RAIN -1.63%

RANI 5.08%

RAPT -3.25%

RARE 1.76%

RCKT -3.56%

REGN -1.52%

RENB -3.42%

REPL -0.91%

RETA 0.02%

REUN -0.89%

REVB -5.12%

REVBU 3.46%

REVBW -18.13%

RGLS -4.44%

RGNX -3.65%

RIGL -1.13%

RLAY -4.75%

RLMD 0.17%

RLYB 1.34%

RNA -0.85%

RNAC -1.85%

RNAZ 1.92%

RNXT 4.84%

ROIV -0.92%

ROIVW 4.56%

RPHM 0.62%

RPRX 0.22%

RPTX -1.66%

RUBY 2.70%

RVLP -32.05%

RVMD -0.44%

RVMDW 5.10%

RVNC 1.70%

RVPH 0.00%

RVPHW 1.62%

RXDX 0.09%

RXRX -2.11%

RYTM -3.67%

RYZB 0.02%

RZLT 2.07%

SABS 0.00%

SABSW -11.81%

SAGE -0.64%

SANA -2.95%

SAVA -0.99%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 7.09%

SCPH 0.38%

SCPS 0.00%

SEEL -4.09%

SEER -0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 1.14%

SGMT 0.72%

SGTX -2.56%

SIOX 22.63%

SLDB -3.97%

SLGL 2.97%

SLN -4.21%

SLNO -2.07%

SLRX 4.73%

SLS -1.84%

SMMT 0.38%

SNDX -0.82%

SNGX 1.70%

SNPX -0.32%

SONN -0.82%

SPPI -0.49%

SPRB 0.93%

SPRC -1.98%

SPRO 0.23%

SRNE -25.00%

SRPT -0.60%

SRRA 0.00%

SRRK -4.58%

SRZN -2.45%

STAB 0.00%

STOK -2.51%

STRO -2.34%

STSA 0.00%

STTK -2.95%

SURF -0.93%

SVRA 4.21%

SWTX -0.36%

SYBX -2.58%

SYRS -0.75%

TALS -0.73%

TARA -5.26%

TARS -1.78%

TBPH 0.83%

TCBP 2.74%

TCDA 0.00%

TCON -3.38%

TCRR 0.00%

TCRT 5.75%

TCRX 1.78%

TECH -0.05%

TENX -1.27%

TERN -4.97%

TFFP -3.52%

TGTX -2.03%

THRX 0.12%

TIL 0.02%

TLC 0.00%

TLSA -2.07%

TNGX 0.27%

TNXP -2.41%

TNYA -4.73%

TPST 0.00%

TRDA -2.71%

TRVI -0.77%

TRVN 1.69%

TSHA -19.88%

TSVT -3.06%

TTNP -6.21%

TVTX -0.50%

TYRA -5.22%

UBX -0.48%

UNCY -3.80%

URGN -3.11%

UTHR -0.02%

VACC 11.36%

VALN -2.65%

VAXX 150.63%

VBIV 0.76%

VBLT -8.77%

VCEL -0.53%

VCNX 9.01%

VCYT -0.18%

VERA -2.58%

VERU -1.85%

VERV -1.81%

VIGL 4.30%

VINC 2.30%

VIR 1.41%

VIRI -3.16%

VIRX 3.24%

VKTX -0.70%

VLON -13.04%

VNDA -1.30%

VOR -1.61%

VRCA 2.33%

VRDN -4.39%

VRNA 0.53%

VRPX 0.20%

VRTX 0.92%

VSTM -3.75%

VTGN -0.75%

VTVT -6.43%

VTYX -2.09%

VXRT -0.28%

VYGR -1.53%

VYNE -4.55%

VYNT 7.78%

WINT -3.24%

WVE -4.09%

XBIO 1.44%

XBIT -1.03%

XCUR 6.49%

XENE -1.97%

XERS 2.14%

XFOR 1.98%

XLO 4.43%

XLRN 0.00%

XNCR 0.10%

XOMA -5.07%

XOMAO 0.36%

XOMAP -0.82%

XRTX -7.04%

YMAB -2.23%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.62%

ZNTL -4.27%

ZSAN 0.00%

相関 (AI algo v.1.1b): Undervalued: 0.07% $3.00 paired level. (アルゴリズムは、最も相関の高い株式の変更をリアルタイムで追跡し、即時の更新を提供します)

immatics biotechnologies 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

immatics biotechnologies 財務諸表

Annual	2023
収益:	$54.00M
総利益:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2023
収益:	$54.00M
総利益:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2022
収益:	$172.83M
総利益:	$66.05M (38.22 %)
EPS:	$0.550

Financial Reports:

No articles found.

immatics biotechnologies Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

immatics biotechnologies

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.